Medirom Healthcare TechnologMRM
13F holders, Q4 2024 (December 31)5holders +2
4new positions
2sold out
$1.04avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Medirom Healthcare Technolog (MRM) in their 13F filings, up 2 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were UBS Group AG ($47K), Heights Capital Management, Inc. ($37K) and Warberg Asset Management LLC ($24K).
- Company
- Medirom Healthcare Technolog
- CUSIP
- 58510H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $80K |
| Exits | 2 | $33K |
All 13F filers, Q3 2024 → Q4 2024: 104,113 shares bought and 10,967 shares sold, net +93,146 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +150.4% | 45,174 | $47K |
| Heights Capital Management, Inc. | 0.02% | New | 35,582 | $37K |
| Warberg Asset Management LLC | 0.09% | New | 22,919 | $24K |
| XTX Topco Ltd | 0.00% | New | 13,558 | $14K |
| GAMMA Investing LLC | 0.00% | New | 4,917 | $5K |
"% of holder's portfolio" is MRM's weight in each manager's 13F, not the share of Medirom Healthcare Technolog the manager owns.